Your browser doesn't support javascript.
loading
Plasma endotoxin activity rises during ischemic stroke and is associated with worse short-term outcome.
Klimiec, Elzbieta; Pera, Joanna; Chrzanowska-Wasko, Joanna; Golenia, Aleksandra; Slowik, Agnieszka; Dziedzic, Tomasz.
Afiliación
  • Klimiec E; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Pera J; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Chrzanowska-Wasko J; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Golenia A; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Slowik A; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Dziedzic T; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland. Electronic address: Dziedzic@cm-uj.krakow.pl.
J Neuroimmunol ; 297: 76-80, 2016 08 15.
Article en En | MEDLINE | ID: mdl-27397079
BACKGROUND: Activation of Toll-like receptor 4 (TLR4) contributes to brain injury and poor outcome after cerebral ischemia. The expression of this receptor on monocytes is increased in patients with acute ischemic stroke. Endotoxin is an endogenous ligand for TLR4. The aim of our study was to determine if plasma endotoxin activity is increased in stroke patients and correlates with functional outcome. METHODS: We included 88 patients with ischemic stroke (median age: 71, 56.8% men) and 59 age-matched controls. Plasma endotoxin activity and level of proteins regulating endotoxin interaction with TLR4 (LPS binding protein - LBP and sCD14) were measured in blood samples taken at day 1 (within 24h after stroke symptoms onset), 3 and 6. Short-term functional outcome was assessed at day 14 using modified Rankin Scale. Unfavourable outcome was defined as modified Rankin Scale score>2. RESULTS: Compared to controls, stroke patients had higher plasma endotoxin activity on day 1 (median: 0.39 vs 0.32EU/mL, P=0.03) as well as higher LBP (median: 18.7 vs 11.5µg/mL, P<0.01) and sCD14 level (median: 1330 vs 1070ng/mL, P<0.01). Plasma LPS activity and levels of LBP and sCD14 significantly rose during stroke. Higher LPS activity measured on day 6 was associated with unfavourable outcome (OR: 3.94, 95%CI: 1.03-15.02, P=0.04, adjusted for age and stroke severity). CONCLUSIONS: Plasma endotoxin activity rises during ischemic stroke and is associated with worse short-term outcome.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Endotoxinas Tipo de estudio: Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Año: 2016 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular / Endotoxinas Tipo de estudio: Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Año: 2016 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Países Bajos